A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
Clinical trial NCT01470131 · TERMINATED
Trial details
- NCT number
- NCT01470131
- Sponsor
- AB Science
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2017-01-04
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.